T
Twist Bioscience
Silicon-Based DNA Synthesis
South San Francisco, CA
1,000+
About Twist Bioscience
Industry:
Synthetic Biology/Genomics
Founded:
2013
Founders:
Emily Leproust, Bill Banyai, Bill Peck
Status:
Public (NASDAQ: TWST)
Funding & Growth
Total Raised:
$800M+
Valuation:
$2B+ market cap
Stage:
Public
Key Investors:
Illumina
ARCH Venture
Polaris Partners
✓ Pros
- • Revolutionary DNA synthesis platform
- • Diverse product portfolio
- • Bay Area biotech hub
- • High-growth company
- • Innovative technology
✗ Cons
- • Fast-paced/demanding culture
- • Some management challenges
- • Work-life balance concerns
- • Rapid scaling growing pains